Jessika J.
- Country
- Germany
- Department
- 462: Nephrology and Rheumatology
Research Overview
- Evaluation of Clinical Outcomes of Nusinersen in Patients with Spinal Muscular Atrophy Post-Onasemnogene Abeparvovec Administration
- Evaluation of the Safety and Efficacy of Delandistrogene Moxeparvovec in Non-Ambulatory and Ambulatory Duchenne Muscular Dystrophy Patients
- Long-term Safety, Tolerability, and Efficacy Evaluation of Givinostat in Duchenne Muscular Dystrophy Patients Previously Enrolled in Givinostat Trials
Data & Insights
Has run more than one trial at 11 of 35 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in treating severe progressive neuromuscular conditions, with particular emphasis on Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA).
- Gene Transfer Therapies
- Novel Therapeutic Approaches
- Progressive Muscle Disorders
The investigator focuses on evaluating innovative treatments for patients with degenerative muscle conditions.
Therapeutic Innovation
Expertise in evaluating advanced therapeutic solutions including gene transfer therapies and long-term treatment approaches for neuromuscular disorders.
- Treatment Safety Assessment
- Clinical Outcomes Evaluation
- Long-term Efficacy Studies
The research encompasses both ambulatory and non-ambulatory patient populations requiring specialized therapeutic interventions.
Clinical Assessment
Specialized in measuring therapeutic outcomes through performance-based assessments and comprehensive patient monitoring.
- Upper Limb Performance Evaluation
- Treatment Response Analysis
- Safety Monitoring Protocols
Focus on evaluating functional improvements and therapeutic responses in patients with progressive muscle disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.